Covid-19
Conditions
Keywords
COVID-19, SARS-CoV-2, VIRTUES, Virtual Care Management, Virtual Care, Patient Satisfaction, Anxiety, Emergency Visits, Oxygen Saturation, Quality of Life
Brief summary
This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario. This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.
Interventions
Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home
Sponsors
Study design
Intervention model description
Prospective non-randomized cohort study
Eligibility
Inclusion criteria
* All COVID-19 positive patients of age 18 or above * Participant must communicate in English or French language * An email address and account
Exclusion criteria
* Unable or unwilling to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 14 Day Patient Satisfaction Questionnaire | 14 days | The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 14 days. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Emergency Department Visits | 14 days | The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 14 days. |
| 14 Day EQ-5D-5L Scores | 14 days | The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 14 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status. |
Countries
Canada